Stratum Nutrition, a US supplier of functional ingredients, has entered into an exclusive distribution agreement with OraTicx.
The company will be solely responsible for the distribution of OraTicx's range of specialist oral probiotics, including the live strains oraCMU and oraCMS1, as well as the postbiotic form of oraCMU.
The agreement will bring the product range to North America, and will target the oral hygiene category.
OraTicx has published a number of human clinical studies exhibiting oraCMU's ability to promote the balance of the oral microbiome balance, while also helping consumers improve dental health and maintain fresh breath.
In a recently published clinical trial, volunteers taking oraCMU showed significant improvement in their breath scores, while also seeing a reduction in the compounds that can cause bad breath.1
"OraTicx's high-quality oral probiotics will further strengthen our portfolio of clinically proven ingredients,” said the CEO of Stratum Nutrition, Micah Osborne. “We are pleased to offer more diverse and effective health solutions to North American consumers in both human and pet markets through this partnership."
"This exclusive distribution agreement with Stratum Nutrition is an important opportunity for us to introduce our innovative oral probiotics to North American consumers,” added Eun-Seop Yoon, CEO of OraTicx. “By combining the expertise of both companies, we will create new value in the North American health functional food market and grow into a global leading company that contributes to a healthy life."